Pfizer Inc. (BMV:PFE)

Market Cap	2.69T
Revenue (ttm)	1.28T
Net Income (ttm)	161.05B
Shares Out	n/a
EPS (ttm)	28.26
PE Ratio	16.71
Forward PE	8.91
Dividend	33.26 (6.93%)
Ex-Dividend Date	May 9, 2025

Volume	44
Average Volume	21,550
Open	473.34
Previous Close	473.34
Day's Range	470.00 - 479.99
52-Week Range	427.00 - 597.50
Beta	0.49
RSI	65.66
Earnings Date	Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD